Latest news

• CHMP recommends use of Moderna’s Omicron BA.1 booster in children in the EU

  The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the use of Moderna’s Omicron BA.1 targeting bivalent booster – mRNA-1273.214 – in ... against Omicron when compared to a dose of the

• Pfizer/BioNTech submit FDA application for BA.4/BA.5 COVID-19 vaccine in children under five

  Pfizer and BioNTech’s bivalent vaccine contains mRNA encoding the original SARS-CoV-2 spike protein – present in the original Pfizer/BioNTech COVID-19 vaccine – together with mRNA encoding the spike ... mRNA-1273.214 contains the BA.1 Omicron strain

• Moderna’s bivalent Omicron-targeting boosters show superiority to original COVID-19 vaccine

  antibody response against BA.1 compared to a booster dose of mRNA-1273. ... Both bivalent candidates contain 25µg of mRNA-1273 and 25µg of an Omicron subvariant.

• Moderna’s Omicron BA.1 booster shows superior antibody response over Spikevax

  mRNA-1273.214 contains the BA.1 Omicron strain, while mRNA-1273.222 contains the BA.4/BA.5 Omicron strain. ... Both bivalent candidates contain 25µg of mRNA-1273 and 25µg of an Omicron subvariant.

• Moderna and Gavi update COVAX supply deal to include variant-specific COVID-19 vaccines

  mRNA-1273.222 contains the BA.4/BA.5 Omicron strain, while mRNA-1273.214 contains the BA.1 Omicron strain. ... Both bivalent candidates contain 25µg of mRNA-1273 and 25µg of an Omicron subvariant.